Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 3
1998 4
1999 2
2000 7
2001 3
2002 4
2003 2
2004 7
2005 7
2006 12
2007 10
2008 11
2009 21
2010 20
2011 15
2012 29
2013 24
2014 27
2015 30
2016 20
2017 29
2018 33
2019 49
2020 30
2021 27
2022 34
2023 28

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Nölting S, et al. Among authors: beuschlein f. Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019. Endocr Rev. 2022. PMID: 34147030 Free PMC article. Review.
An Update on Addison's Disease.
Barthel A, Benker G, Berens K, Diederich S, Manfras B, Gruber M, Kanczkowski W, Kline G, Kamvissi-Lorenz V, Hahner S, Beuschlein F, Brennand A, Boehm BO, Torpy DJ, Bornstein SR. Barthel A, et al. Among authors: beuschlein f. Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):165-175. doi: 10.1055/a-0804-2715. Epub 2018 Dec 18. Exp Clin Endocrinol Diabetes. 2019. PMID: 30562824 Free article. Review.
COVID-19 and metabolic disease: mechanisms and clinical management.
Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, Tkachuk VA, Markov AG, Lehnert H, de Angelis MH, Rietzsch H, Rodionov RN, Khunti K, Hopkins D, Birkenfeld AL, Boehm B, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Alberti KGMM, Geloneze B, Chan JC, Mbanya JC, Onyegbutulem HC, Ramachandran A, Basit A, Hassanein M, Bewick G, Spinas GA, Beuschlein F, Landgraf R, Rubino F, Mingrone G, Bornstein SR. Steenblock C, et al. Among authors: beuschlein f. Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798. doi: 10.1016/S2213-8587(21)00244-8. Epub 2021 Oct 4. Lancet Diabetes Endocrinol. 2021. PMID: 34619105 Free PMC article. Review.
Targeted Therapies in Pheochromocytoma and Paraganglioma.
Wang K, Crona J, Beuschlein F, Grossman AB, Pacak K, Nölting S. Wang K, et al. Among authors: beuschlein f. J Clin Endocrinol Metab. 2022 Nov 23;107(11):2963-2972. doi: 10.1210/clinem/dgac471. J Clin Endocrinol Metab. 2022. PMID: 35973976 Free PMC article. Review.
Perioperative Management of Endocrine Active Adrenal Tumors.
Schreiner F, Anand G, Beuschlein F. Schreiner F, et al. Among authors: beuschlein f. Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):137-146. doi: 10.1055/a-0654-5251. Epub 2018 Aug 14. Exp Clin Endocrinol Diabetes. 2019. PMID: 30107625 Free article. Review.
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network; Hammer GD, Giordano TJ, Verhaak RGW. Zheng S, et al. Among authors: beuschlein f. Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Cancer Cell. 2016. PMID: 27165744 Free PMC article.
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. Among authors: beuschlein f. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.
Hypokalemia and the Prevalence of Primary Aldosteronism.
Gruber S, Beuschlein F. Gruber S, et al. Among authors: beuschlein f. Horm Metab Res. 2020 Jun;52(6):347-356. doi: 10.1055/a-1134-4980. Epub 2020 Apr 6. Horm Metab Res. 2020. PMID: 32252108 Review.
International Histopathology Consensus for Unilateral Primary Aldosteronism.
Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A, Mete O, Yamazaki Y, Zerbini MCN, Beuschlein F, Satoh F, Burrello J, Schneider H, Lenders JWM, Mulatero P, Castellano I, Knösel T, Papotti M, Saeger W, Sasano H, Reincke M. Williams TA, et al. Among authors: beuschlein f. J Clin Endocrinol Metab. 2021 Jan 1;106(1):42-54. doi: 10.1210/clinem/dgaa484. J Clin Endocrinol Metab. 2021. PMID: 32717746 Free PMC article.
Identification of risk loci for primary aldosteronism in genome-wide association studies.
Le Floch E, Cosentino T, Larsen CK, Beuschlein F, Reincke M, Amar L, Rossi GP, De Sousa K, Baron S, Chantalat S, Saintpierre B, Lenzini L, Frouin A, Giscos-Douriez I, Ferey M, Abdellatif AB, Meatchi T, Empana JP, Jouven X, Gieger C, Waldenberger M, Peters A, Cusi D, Salvi E, Meneton P, Touvier M, Deschasaux M, Druesne-Pecollo N, Boulkroun S, Fernandes-Rosa FL, Deleuze JF, Jeunemaitre X, Zennaro MC. Le Floch E, et al. Among authors: beuschlein f. Nat Commun. 2022 Sep 3;13(1):5198. doi: 10.1038/s41467-022-32896-8. Nat Commun. 2022. PMID: 36057693 Free PMC article.
428 results